| Long name: |
TAB3 Primary Polyclonal Antibody |
| Also known as: |
TAB3 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
TAB1 |
| Specificity: |
This is a highly specific antibody against TAB1 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human TAB3 |
| Gene ID number: |
257397 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Alternatively spliced transcript variants have been described, Subsequent MAP3K7/TAK1 kinase activity triggers a signaling cascade leading to activation of the NF-kappaB transcription factor, The encoded protein, The human genome contains a related pseudogene, and the similar and functionally redundant protein MAP3K7IP2/TAB2, but their biological validity has not been determined, forms a ternary complex with the protein kinase MAP3K7/TAK1 and either TRAF2 or TRAF6 in response to stimulation with the pro-inflammatory cytokines TNF or IL-1, The product of this gene functions in the NF-kappaB signal transduction pathway |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
Mitogen activated protein kinase kinase kinase 7 interacting protein 3, Mitogen-activated protein kinase kinase kinase 7-interacting protein 3, NAP1, NF kappa B activating protein 1, NF-kappa-B-activating protein 1, NFkB activating protein 1, TAB-3, TAB3, TAB3_HUMAN, TAK1 binding protein 3, TAK1-binding protein 3, TGF-beta-activated kinase 1 and MAP3K7-binding protein 3, TGF-beta-activated kinase 1-binding protein 3, MAP3K7IP 3 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
TAB3 |
| Short name: |
TAB3 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
TAB3 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
30681 |
| Gene: |
TAB3 |
More about : TAB3 |
| Long gene name: |
TGF-beta activated kinase 1 and MAP3K7 binding protein 3 |
| Synonyms gene: |
MAP3K7IP3 |
| Synonyms gene name: |
mitogen-activated protein kinase kinase kinase 7 interacting protein 3 TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
| Synonyms name: |
TAK1 binding protein 3 |
| Locus: |
Xp21, 2 |
| Discovery year: |
2006-06-26 |
| GenBank acession: |
AY331591 |
| Entrez gene record: |
257397 |
| Pubmed identfication: |
14633987 14670075 |
| RefSeq identity: |
NM_152787 |
| Classification: |
Zinc fingers RANBP2-type |
| Havana BLAST/BLAT: |
OTTHUMG00000021329 |
| Locus Specific Databases: |
Mental Retardation database |